These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31054981)

  • 41. PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY IN ROMANIAN CIRRHOTIC PATIENTS--PARTIAL RESULTS.
    Badea MA; Prelipcean CC; Mihai C; Popa I; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):368-73. PubMed ID: 26204638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.
    Bachofner JA; Valli PV; Kröger A; Bergamin I; Künzler P; Baserga A; Braun D; Seifert B; Moncsek A; Fehr J; Semela D; Magenta L; Müllhaupt B; Terziroli Beretta-Piccoli B; Mertens JC
    Liver Int; 2017 Mar; 37(3):369-376. PubMed ID: 27678216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals.
    Argalia G; Tarantino G; Ventura C; Campioni D; Tagliati C; Guardati P; Kostandini A; Marzioni M; Giuseppetti GM; Giovagnoni A
    Radiol Med; 2021 Jun; 126(6):894-899. PubMed ID: 33492651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy.
    Knop V; Hoppe D; Welzel T; Vermehren J; Herrmann E; Vermehren A; Friedrich-Rust M; Sarrazin C; Zeuzem S; Welker MW
    J Viral Hepat; 2016 Dec; 23(12):994-1002. PubMed ID: 27500382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens.
    Attia D; Deterding K; Cornberg J; Gebel MJ; Cornberg M; Manns MP; Wedemeyer H; Potthoff A
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):67-74. PubMed ID: 30239347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).
    Badea MA; Drug VL; Dranga M; Gavrilescu O; Stefanescu G; Popa I; Mihai C; Cijevschi-Prelipcean C
    Metab Brain Dis; 2016 Dec; 31(6):1463-1471. PubMed ID: 27461111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study.
    Tan HH; Lee GH; Thia KT; Ng HS; Chow WC; Lui HF
    Singapore Med J; 2009 Mar; 50(3):255-60. PubMed ID: 19352567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis.
    Roberts S; Gordon A; McLean C; Pedersen J; Bowden S; Thomson K; Angus P
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):932-7. PubMed ID: 17544878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
    Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patients.
    Philonenko S; Rivière P; Mallet M; Poullenot F; Tripon S; Munteanu M; Boukherrouf R; Sultanik P; Roupret M; Thabut D; Rudler M
    Dig Liver Dis; 2019 Jun; 51(6):850-855. PubMed ID: 31031175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C.
    Crisan D; Radu C; Grigorescu MD; Lupsor M; Feier D; Grigorescu M
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):375-82. PubMed ID: 23256120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.
    Cacoub P; Nahon P; Layese R; Blaise L; Desbois AC; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Zucman D; Di Martino V; Bagnis CI; Ziol M; Sutton A; Letouze E; Roudot-Thoraval F; Audureau E;
    Am Heart J; 2018 Apr; 198():4-17. PubMed ID: 29653647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy.
    Stawicka A; Jaroszewicz J; Zbrzeźniak J; Sołowianowicz N; Woszczenko A; Świderska M; Flisiak R
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32455895
    [No Abstract]   [Full Text] [Related]  

  • 58. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.
    Reiberger T; Rutter K; Ferlitsch A; Payer BA; Hofer H; Beinhardt S; Kundi M; Ferenci P; Gangl A; Trauner M; Peck-Radosavljevic M
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):602-8.e1. PubMed ID: 21397726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
    Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J
    Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.